Skip to main content
Equibles

Walleye Capital LLC

Position in GMAB — Genmab A/S

CIK 1758720 NEW YORK, NY
Back to GMAB Full portfolio

Position in GMAB

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$38,512
-$468,762 QoQ
Shares Held
1,402
-92.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#192
of 292 holders
Holding Since
Mar 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GMAB Over Time

Shares Held

Position Value (USD)

Derivatives in GMAB

reported options exposure · as of Jun 30, 2026
CallValue
$1,216,921
CallShares
44,300
PutValue
$85,157
PutShares
3,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names. GMAB ranks #110 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ASND
Ascendis Pharma A/S
 126,005 $33,608,053
2 CYTK
Cytokinetics Inc
 239,728 $20,422,428
3 BMRN
Biomarin Pharmaceutical Inc
 288,233 $16,492,692
4 IDYA
IDEAYA Biosciences, Inc.
 386,183 $14,393,040
5 REGN
Regeneron Pharmaceuticals, Inc.
 22,596 $14,089,509
6 RARE
Ultragenyx Pharmaceutical Inc.
 334,854 $11,180,775
7 TYRA
Tyra Biosciences, Inc.
 347,898 $11,111,862
8 BCAX
Bicara Therapeutics Inc.
 353,226 $10,487,279

All Filings in GMAB

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $85,157 3,100
2026-06-30 $38,512 1,402
2026-06-30 $1,216,921 44,300
2026-03-31 $778,070 29,000
2026-03-31 $507,274 18,907
2025-03-31 $1,387,477 70,862